Technology
Health
Biotechnology

ASLAN Pharmaceuticals

$4.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.25 (-5.71%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ASLN and other stocks, options, ETFs, and crypto commission-free!

About

ASLAN Pharmaceuticals Limited American Depositary Shares, also called ASLAN Pharmaceuticals, is a clinical-stage oncology-focused biopharmaceutical company, which engages in the development of novel therapeutics. Its pipeline includes varlitinib, ASLAN003, ASLAN004, and ASLAN002. Read More The firm's portfolio focuses on validated growth pathways applied to new patient segments, novel immune checkpoints, and novel cancer metabolic pathways. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Employees
Headquarters
Singapore, Central Singapore
Founded
2010
Market Cap
132.37M
Price-Earnings Ratio
Dividend Yield
Average Volume
35.35K
High Today
$4.34
Low Today
$4.19
Open Price
$4.25
Volume
959.00
52 Week High
$10.44
52 Week Low
$2.51

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Therapy
Cancer Prevention
Pharmaceutical

News

Seeking AlphaFeb 26

ASLAN Pharma teams up with BioGenetics to commercialize varlitinib in South Korea

ASLAN Pharmaceuticals (NASDAQ:ASLN) will collaborate with BioGenetics Co. Ltd. to commercialize cancer med varlitinib in South Korea for all indications. Under the terms of the partnership, ASLN will receive $2M upfront, up to $11M in milestones and tiered double-digit up to mid-twenties royalties on net sales. BioGenetics will responsible for regulatory filings while ASLN will continue to fund clinical development....

56

Earnings

-$0.45
-$0.32
-$0.20
-$0.07
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.45 per share
Actual
Expected Mar 27, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.